Literature DB >> 3405553

Impact of primary prevention on the incidence of toxoplasmosis during pregnancy.

W Foulon1, A Naessens, S Lauwers, F De Meuter, J J Amy.   

Abstract

Until now, it was assumed that primary prevention of congenital toxoplasmosis was possible by means of specific hygienic measures. A prospective survey of pregnant women was made at a hospital in Brussels over the period 1979-1986 to assess the impact of such a prevention program. In the first study period (1979-1982), when no prophylactic measures were taught, 2986 consecutive women demonstrated a seroconversion rate of 1.43% among the nonimmunized subjects; 1.07% of the seropositive patients had high antibody levels in their first serum sample. In the second study period (1983-1986), all 3563 patients were instructed to adopt prophylactic measures. The seroconversion rate in seronegative patients and the percentage of patients with high initial antibody level were 0.95 and 1.26%, respectively. Although the percentage of seroconversion was reduced by 34% in the second study period, this difference did not attain significance. These results indicate that the impact of a primary prevention program aimed at reducing congenital toxoplasmosis is limited.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3405553

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

1.  Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia.

Authors:  V Punda-Polić; M Tonkić; V Capkun
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Toxoplasmosis during pregnancy.

Authors:  Ariel Many; Gideon Koren
Journal:  Can Fam Physician       Date:  2006-01       Impact factor: 3.275

3. 

Authors:  P Holhlfeld
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

Review 4.  Prophylaxis of human toxoplasmosis: a systematic review.

Authors:  Senaka Rajapakse; Praveen Weeratunga; Chaturaka Rodrigo; Nipun Lakshitha de Silva; Sumadhya Deepika Fernando
Journal:  Pathog Glob Health       Date:  2017-09-26       Impact factor: 2.894

Review 5.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

6.  Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases.

Authors:  F Robert-Gangneux; M F Gavinet; T Ancelle; J Raymond; C Tourte-Schaefer; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

7.  Prevention of congenital toxoplasmosis; experience in The Netherlands.

Authors:  M A Conyn-van Spaendonck
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

8.  Survey of obstetrician-gynecologists in the United States about toxoplasmosis.

Authors:  J L Jones; V J Dietz; M Power; A Lopez; M Wilson; T R Navin; R Gibbs; J Schulkin
Journal:  Infect Dis Obstet Gynecol       Date:  2001

Review 9.  Pregnancy and susceptibility to infectious diseases.

Authors:  Elisabeth Sappenfield; Denise J Jamieson; Athena P Kourtis
Journal:  Infect Dis Obstet Gynecol       Date:  2013-07-07

Review 10.  Prenatal education for congenital toxoplasmosis.

Authors:  Simona Di Mario; Vittorio Basevi; Carlo Gagliotti; Daniela Spettoli; Gianfranco Gori; Roberto D'Amico; Nicola Magrini
Journal:  Cochrane Database Syst Rev       Date:  2015-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.